For InvestorsAntares Pharma: Making Medicines Feel Better

Press Release Archive

This section contains information and press releases about us. This information should be considered accurate only as of the date prepared. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Antares Pharma, Inc. is not obligated to update the press releases and information contained in this section of the Company’s website.

2021

11 January 2021
Antares Pharma Announces Full-Year 2021 Revenue Guidance of $175-200 Million

17 February 2021
Antares Pharma to Participate in the SVB Leerink 10th Annual Virtual Global Healthcare Conference

23 February 2021
Antares Pharma to Report Fourth Quarter And Full-Year 2020 Financial and Operating Results

24 February 2021
Antares Pharma to Present At Two Upcoming Investor Conferences

02 March 2021
Antares Pharma Reports Fourth Quarter and Full-Year 2020 Financial and Operating Results

26 April 2021
Antares Pharma Appoints Dr. Peter Richardson As Executive Vice President, Research And Development And Chief Medical Officer

27 April 2021
Antares Pharma to Report First Quarter 2021 Financial and Operating Results

28 April 2021
Antares Pharma To Participate In The 7th Annual Truist Securities 2021 Life Sciences Summit

03 May 2021
Antares Pharma Announces Poster Presentation At The Pediatric Endocrine Society 2021 Virtual Annual Meeting

06 May 2021
Antares Pharma Reports First Quarter 2021 Financial and Operating Results

06 May 2021
Antares Pharma Appoints Joseph Renda as Senior Vice President of Commercial

26 May 2021
Antares Pharma to Present at the Jefferies Virtual Healthcare Conference

15 June 2021
Antares Pharma to Present at the Raymond James Human Health Innovations Conference

22 June 2021
Antares Pharma Announces Submission of IND Application for ATRS 1902 For Adrenal Crisis Rescue

28 June 2021
Antares Pharma Announces Partner Idorsia Initiates The Phase 3 Study with Selatogrel For Acute Myocardial Infarction

07 July 2021
Antares Pharma To Present At The Ladenburg Thalmann Annual Healthcare Conference

22 July 2021
Antares Pharma Announces FDA Acceptance of IND Application for ATRS 1902 For Adrenal Crisis Rescue

28 July 2021
Antares Pharma to Report Second Quarter 2021 Financial and Operating Results

05 August 2021
Antares Pharma Reports Second Quarter 2021 Financial And Operating Results

08 September 2021
Antares Pharma to Participate in the H.C. Wainright 23rd Annual Global Investment Conference

30 September 2021
Antares Pharma Initiates Phase I Study for ATRS-1902 for Adrenal Crisis Rescue

18 October 2021
Antares Pharma Enters Into Exclusive License Agreement with Lipocine for TLANDO® in U.S.

21 October 2021
Antares Pharma to Report Third Quarter 2021 Financial and Operating Results

25 October 2021
Antares Pharma Announces Oral Presentation at the 22nd Annual Fall Scientific Meeting of SMSNA

28 October 2021
Antares Pharma Announces Appointment of Carmen Volkart to its Board of Directors

04 November 2021
Antares Pharma Reports Third Quarter 2021 Financial and Operating Results

10 November 2021
Antares Pharma to Present at the Jefferies London Healthcare Conference

22 November 2021
Antares Pharma to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

For Investors

Press Archive

  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016


  • Sign up for breaking news on ATRS

    * indicates required